StoryCompare

COVERAGE GAP

Novo Nordisk Q3 Earnings Beat on Wegovy

Novo Nordisk reported earnings above expectations driven by strong Wegovy pill sales.

COVERAGE GAPLEFT SOURCES ONLY

NOT REPORTED ELSEWHERE

  • ▸Wegovy pill sales significantly exceeded estimates in quarterly earnings. — CNBC
  • ▸CEO Mike Doustdar expects FDA approval for CagriSema obesity drug by year-end. — Bloomberg Markets

Keep comparing